BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36464512)

  • 1. Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals.
    Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Zou X; Flaws JA
    Am J Pathol; 2023 Jan; 193(1):84-102. PubMed ID: 36464512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.
    Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Wong J; Shearer C; Zou X; Flaws JA
    Am J Pathol; 2023 Jan; 193(1):103-120. PubMed ID: 36464513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
    Dabydeen SA; Kang K; Díaz-Cruz ES; Alamri A; Axelrod ML; Bouker KB; Al-Kharboosh R; Clarke R; Hennighausen L; Furth PA
    Carcinogenesis; 2015 Jan; 36(1):122-32. PubMed ID: 25421723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen impairs prepubertal mammary development and alters expression of estrogen receptor α (ESR1) and progesterone receptors (PGR).
    Tucker HL; Parsons CL; Ellis S; Rhoads ML; Akers RM
    Domest Anim Endocrinol; 2016 Jan; 54():95-105. PubMed ID: 26619291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor alpha (Esr1) regulates aromatase (Cyp19a1) expression in the mouse brain.
    Yilmaz MB; Zhao H; Brooks DC; Fenkci IV; Imir-Yenicesu G; Attar E; Akbal E; Kaynak BA; Bulun SE
    Neuro Endocrinol Lett; 2015; 36(2):178-82. PubMed ID: 26071589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
    Johansson H; Gray KP; Pagani O; Regan MM; Viale G; Aristarco V; Macis D; Puccio A; Roux S; Maibach R; Colleoni M; Rabaglio M; Price KN; Coates AS; Gelber RD; Goldhirsch A; Kammler R; Bonanni B; Walley BA;
    Breast Cancer Res; 2016 Nov; 18(1):110. PubMed ID: 27825388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology.
    Mandava U; Kirma N; Tekmal RR
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):27-34. PubMed ID: 11850204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase promoter I.f is regulated by estrogen receptor alpha (ESR1) in mouse hypothalamic neuronal cell lines.
    Yilmaz MB; Wolfe A; Cheng YH; Glidewell-Kenney C; Jameson JL; Bulun SE
    Biol Reprod; 2009 Nov; 81(5):956-65. PubMed ID: 19605792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer.
    Liang J; Ingalla ER; Yao X; Wang BE; Tai L; Giltnane J; Liang Y; Daemen A; Moore HM; Aimi J; Chang CW; Gates MR; Eng-Wong J; Tam L; Bacarro N; Roose-Girma M; Bellet M; Hafner M; Metcalfe C
    Sci Transl Med; 2022 Sep; 14(663):eabo5959. PubMed ID: 36130016
    [No Abstract]   [Full Text] [Related]  

  • 10. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
    Tekmal RR; Kirma N; Gill K; Fowler K
    Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male mammary gland development and methylation status of estrogen receptor alpha in Wistar rats are modified by the developmental exposure to a glyphosate-based herbicide.
    Gomez AL; Altamirano GA; Leturia J; Bosquiazzo VL; Muñoz-de-Toro M; Kass L
    Mol Cell Endocrinol; 2019 Feb; 481():14-25. PubMed ID: 30447247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice.
    Luthra R; Kirma N; Jones J; Tekmal RR
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):461-7. PubMed ID: 14623545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
    Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of CYP19A1 expression in chickens: ESR1, ESR2 and NR5A2 form a functional network.
    Guo Y; Cheng L; Li X; Tang S; Zhang X; Gong Y
    Gen Comp Endocrinol; 2022 Jan; 315():113939. PubMed ID: 34710471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in
    Kumagai H; Miyamoto-Mikami E; Takaragawa M; Kuriki K; Goto C; Shibata K; Yamada N; Hosono A; Fuku M; Suzuki S; Fuku N
    J Appl Physiol (1985); 2022 Apr; 132(4):966-973. PubMed ID: 35175101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of
    Alothman SJ; Wang W; Goerlitz DS; Islam M; Zhong X; Kishore A; Azhar RI; Kallakury BV; Furth PA
    Cancer Prev Res (Phila); 2017 Apr; 10(4):244-254. PubMed ID: 28283467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CYP19A1 gene variations with adjuvant letrozole-induced adverse events in South Indian postmenopausal breast cancer cohort expressing hormone-receptor positivity.
    Umamaheswaran G; Kadambari D; Muthuvel SK; Kalaivani S; Devi J; Damodaran SE; Pradhan SC; Dubashi B; Dkhar SA; Adithan C
    Breast Cancer Res Treat; 2020 Jul; 182(1):147-158. PubMed ID: 32385792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
    Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
    Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor 1 and progesterone receptor in primary goat mammary epithelial cells.
    Ogorevc J; Dovč P
    Anim Sci J; 2016 Dec; 87(12):1464-1471. PubMed ID: 27018494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.
    Verma S; Salmans ML; Geyfman M; Wang H; Yu Z; Lu Z; Zhao F; Lipkin SM; Andersen B
    Dev Biol; 2012 Sep; 369(2):249-60. PubMed ID: 22819674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.